Yuyao Lin

Yuyao Lin

Auto-generated profile, based on publicly available information

Yuyao Lin

Department of Cardiovascular Medicine, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in Acta Biomaterialia
Verified
Journal Article
Closed access
JLJiesi Luo
Jiesi Luo
YLYuyao Lin
Yuyao Lin
XSXiangyu Shi
Xiangyu Shi
GLGuangxin Li
Guangxin Li
MKMehmet H. Kural
Mehmet H. Kural
YQYibing Qyang
Yibing Qyang

1 February 2021 in Journal of Investigative Medicine
Verified
Journal Article
Open access
PDF file
YLYuyao Lin
Yuyao Lin
YXYanbo Xue
Yanbo Xue
JLJing Liu
Jing Liu
XWXiqiang Wang
Xiqiang Wang
LWLinyan Wei
Linyan Wei
AMAiqun Ma
Aiqun Ma
Assessing congestion is challenging but important to patients with chronic heart failure (CHF). However, there are limited data regarding the association between estimated plasma volume status (ePVS) determined using hemoglobin/hematocrit data and outcomes in patients with stable CHF. We prospectively analyzed 231 patients; the median follow-up period was 35.6 months. We calculated ePVS at admission using the Duarte and Strauss formula, derived from hemoglobin and hematocrit ratios and divided patients into three groups. The primary outcome was a composite of all-cause mortality or heart failure rehospitalization. Among 274 patients (61.98 years of age, 2.3% male), the mean ePVS was 3.98±0.90 dL/g. The third ePVS tertile had a higher proportion of primary outcome (71.4%) than the first or second tertile (48.1% and 59.7%, respectively; p=0.013). On multivariable Cox analysis, after adjusting for potential confounders, higher ePVS remained significantly associated with increased rate of primary outcome (adjusted HR 1.567, 95% CI 1.267 to 1.936; p<0.001). Kaplan-Meier survival analyses showed that the occurrence of primary outcome, all-cause mortality and rehospitalization increased progressively from first to third tertiles (p=0.006, 0.014 and 0.001; respectively). In receiver operating characteristic analysis, the area under the curve of ePVS for primary outcome was 0.645. ePVS determined using hemoglobin and hematocrit was independently associated with clinical outcomes for patients with stable CHF. Our study thus further strengthens the evidence that ePVS has important prognostic value in patients with stable CHF. Trial registration number ChiCTR-ONC-14004463.